Correlation Between Verona Pharma and Verve Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Verona Pharma and Verve Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verona Pharma and Verve Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verona Pharma PLC and Verve Therapeutics, you can compare the effects of market volatilities on Verona Pharma and Verve Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verona Pharma with a short position of Verve Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verona Pharma and Verve Therapeutics.

Diversification Opportunities for Verona Pharma and Verve Therapeutics

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Verona and Verve is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Verona Pharma PLC and Verve Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verve Therapeutics and Verona Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verona Pharma PLC are associated (or correlated) with Verve Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verve Therapeutics has no effect on the direction of Verona Pharma i.e., Verona Pharma and Verve Therapeutics go up and down completely randomly.

Pair Corralation between Verona Pharma and Verve Therapeutics

Given the investment horizon of 90 days Verona Pharma PLC is expected to generate 0.63 times more return on investment than Verve Therapeutics. However, Verona Pharma PLC is 1.58 times less risky than Verve Therapeutics. It trades about 0.23 of its potential returns per unit of risk. Verve Therapeutics is currently generating about 0.0 per unit of risk. If you would invest  3,367  in Verona Pharma PLC on August 30, 2024 and sell it today you would earn a total of  623.00  from holding Verona Pharma PLC or generate 18.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Verona Pharma PLC  vs.  Verve Therapeutics

 Performance 
       Timeline  
Verona Pharma PLC 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Verona Pharma PLC are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Verona Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.
Verve Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Verve Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Verona Pharma and Verve Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Verona Pharma and Verve Therapeutics

The main advantage of trading using opposite Verona Pharma and Verve Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verona Pharma position performs unexpectedly, Verve Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verve Therapeutics will offset losses from the drop in Verve Therapeutics' long position.
The idea behind Verona Pharma PLC and Verve Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities